Homie Recipes Completes Acquisition of Stevva Ltd. and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
52
Homie Recipes Completes Acquisition of Stevva Ltd. and Enters Rapidly Expanding Global Stevia Market

PELLA GIANNITSA, GREECE--(Marketwired - Aug 21, 2017) - Homie Recipes, Inc. ( OTC PINK : HOMR ) ("Homie" or the "Company"), is pleased to announce the completion of the acquisition of Stevva Ltd. Stevva Ltd. ("STVV") is a Greek company which owns prime farmlands in Pella Giannitsa, Greece. The acquisition allows the Company to focus on the acquired land, which is to grow and cultivate "stevia", a low-carbohydrate food and beverage sweetener, on the newly acquired lands. The new direction of the Company will be led by management with extensive experience and connections in the global stevia marketplace.

Stevia is a low-carbohydrate food and beverage sweetener and sugar substitute. Stevia has absolutely zero-calories and is as much as 300 times sweeter than sugar. Over 80% of stevia is grown and processed in China. For purchasers looking for non-Chinese sourced stevia, the Pella Giannitsa region of Greece has ideal climate and agricultural conditions for producing large quantities of the highest quality stevia.

Pursuant to the completed Share Exchange Agreement, the Company acquired 100% of the issued and outstanding equity of STVV in exchange for an aggregate of 45,000,000 shares of Company common stock. As result of the completed transaction, STVV is now a wholly-owned subsidiary of the Company. Also, pursuant to the completed Share Exchange Agreement, the Company's majority shareholder submitted 39,000,980 shares of its restricted common stock beneficially owned by him for cancellation and were returned to the Company's treasury. Following the completion of the transaction, there are 75,819,000 common shares of the Company issued and outstanding.

As a result of the Share Exchange Agreement, Mr. Theodoros Kerasidis, President and founder of Stevva, Ltd., was appointed a member of the Company's Board of Directors and as the Company's President, Chief Executive Officer, Chief Financial Officer and Secretary. Mr. Jose Mari C. Chin resigned from all positions with the Company.

Mr. Kerasidis is a seasoned agricultural executive and a pioneer in EU stevia growing having founded one of the first ever commercial stevia plantations in Europe. Prior to founding Stevva Ltd. and joining Homie Recipes, Mr. Kerasidis was President of Agricultural Cooperative Stevia (ACS). As President of ACS, he was responsible for the organization which was founded to promote stevia adoption by Greek and EU farmers.

Mr. Kerasidis commented, "We are very pleased to have Homie Recipes acquire 100% of Stevva Ltd. and its land holdings in Greece for growing our future high-quality stevia crops. We look forward to leveraging our extensive experience in stevia production to establish the Company as a global leader in the rapidly expanding market for stevia."

Homie Recipes, Inc. files financial and other regulatory reports with the Securities & Exchange Commission on EDGAR. The Company's filings can be viewed at www.sec.gov .

Cautionary Language Concerning Forward-Looking Statements Some statements in this news release contain forward-looking information or forward-looking statements for the purposes of applicable securities laws. These statements address future events and conditions and, as such, involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the statements. Such factors include, among others, the timing and completion of contemplated financings, the actual use of proceeds and the receipt of regulatory approvals. In making the forward-looking statements, the Company has applied several material assumptions including, but not limited to, the assumptions that: (1) the proposed corporate development and expansion plans will proceed as planned; (2) market fundamentals will result in sustained commodities pricing and (3) any additional financing needed will be available on reasonable terms. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise except as otherwise required by applicable securities legislation. These statements are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to our lack of operating history, transitioning from a development company to an operating company, market acceptance of our products and services; operational difficulties relating to international operations; our ability to form and maintain mutually beneficial relationships with customers and strategic partners; changes in economic, political or regulatory conditions or other trends affecting the food sector, and our ability to attract and retain qualified personnel. Further information about these matters can be found in our Securities and Exchange Commission filings. We expressly disclaim any intent or obligation to update these forward-looking statements.

Contact: Homie Recipes, Inc. / Stevva Ltd. Tel: +30 238-202-6939 E-mail: info@stevva.com Website: www.stevva.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

Exro Technologies Reveals Quarterly Progress and Financial Insights

Updated Category News Views 362

Exro Technologies Reports First Quarter Results Exro Technologies Inc. (TSX: EXRO), a prominent tech company specializing in power control solutions for electric vehicles and energy storage, has recently announced its financial results for the first quarter of the year. This highlights their ongoing transition from technology validation towards commercial operations and...

Continue Reading
dsm-firmenich Appoints New Leaders to Propel Future Growth

Updated Category News Views 548

dsm-firmenich Welcomes New Executive Committee Members dsm-firmenich is set to usher in a transformative era by strengthening its Executive Committee, as it embarks on a journey to intensify its consumer-centered approach. This restructuring aims to solidify its standing as a top-tier partner in creation and innovation across the nutrition, health, and beauty sectors. The...

Continue Reading
Insight Partners Rolls Out $12.5B for Software Innovation Growth

Updated Category News Views 805

Insight Partners Launches New Funds to Propel Software Innovation Global software investor, Insight Partners, has recently celebrated a significant milestone by announcing the closing of its thirteenth flagship fund alongside a dedicated buyout co-invest fund, collectively known as "Fund XIII". This announcement is particularly special as it coincides with the firm's 30th...

Continue Reading
Acumatica's AI Innovations Transform Business Operations

Updated Category News Views 123

Acumatica's AI Innovations Transform Business Operations During an inspiring keynote at a recent summit, Acumatica showcased its commitment to revolutionizing business operations with an AI-first product strategy. This innovative approach aims to significantly enhance how small and mid-sized businesses operate, addressing the real-world challenges they face. With advanced...

Continue Reading
Microbiological Testing of Water Market Growth Forecasts

Updated Category News Views 101

The Expanding Microbiological Testing of Water Market As the demand for clean and safe water continues to surge, the global microbiological testing of water market is set to experience significant growth, reaching an impressive $2.3 billion by 2027, with a robust compound annual growth rate (CAGR) of 7.4%. The rising consciousness among consumers regarding the importance...

Continue Reading